Hyperfine to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Hyperfine (Nasdaq: HYPR) announces its participation in the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 1:30 p.m. ET. The company, known for its FDA-cleared portable MRI system Swoop®, strives to enhance patient access to diagnostic imaging. Interested parties can view the live and archived presentation on the company's investor website. The Swoop system enables rapid scans directly at the patient's bedside, providing critical imaging at a lower cost, making it a valuable tool for emergency departments, operating rooms, and intensive care units.

GUILFORD, Conn., Jan. 4, 2022 /PRNewswire/ -- Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that the company will be participating in the upcoming 40^th Annual J.P. Morgan Healthcare Conference.

Hyperfine management is scheduled to present on Monday, January 10, 2022, at 1:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company's website at: https://investors.hyperfine.io.

About Hyperfine
Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the world's first FDA-cleared portable MRI system. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient's bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments (ED), operating rooms (OR) outside the sterile field, and intensive care units (ICU), among others.

Investor Contact
Marissa Bych
Gilmartin Group LLC
investors@hyperfine.io

Media Contact          
Emily Barnes
APCO Worldwide
ebarnes@apcoworldwide.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyperfine-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301453258.html

SOURCE Hyperfine Inc.

FAQ

When will Hyperfine present at the J.P. Morgan Healthcare Conference?

Hyperfine will present on January 10, 2022, at 1:30 p.m. Eastern Time.

How can I access Hyperfine's conference presentation?

You can access the live and archived webcast on Hyperfine's investor website.

What is Hyperfine's main product?

Hyperfine's main product is Swoop®, the world's first FDA-cleared portable MRI system.

What benefits does the Swoop MRI system provide?

Swoop enables rapid diagnosis and treatment at the patient's bedside, enhancing access to life-saving care.

What is the stock symbol for Hyperfine?

The stock symbol for Hyperfine is HYPR.